Transforming growth factor beta 1 may regulate the stability of mature myelin sheaths

Experimental Neurology

Volumn 184, Issue 2, 2003, Pages 857-864

  Day, W Antony ^a   Koishi, Kyoko ^b   McLennan, Ian S ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Knockout; Mice; Node of Ranvier; Schwann cells; Tomacula; Transforming growth factor beta 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL MATURATION; CELL MUTANT; CELL ORGANELLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; INTERNODE; MACROPHAGE; MALE; MOUSE; MYELIN SHEATH; NERVE CELL MEMBRANE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; RANVIER NODE; REGULATORY MECHANISM; SCHWANN CELL; STATISTICAL SIGNIFICANCE; ULTRASTRUCTURE;

EID: 0842320916     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00308-X     Document Type: Article

References (25)

1. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K.V., Suter U. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat. Genet. 11:1995;274-280.
2. Behse F., Buchthal F., Carlsen F., Knappeis G.G. Hereditary neuropathy with liability to pressure palsies. Electrophysiological and histopathological aspects. Brain. 95:1972;777-794.
3. Bonyadi M., Rusholme S.A., Cousins F.M., Su H.C., Biron C.A., Farrall M., Akhurst R.J. Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nat. Genet. 15:1997;207-211.
4. Bronstein J.M. Function of tetraspan proteins in the myelin sheath. Curr. Opin. Neurobiol. 10:2000;552-557.
5. Diebold R.J., Eis M.J., Yin M.Y., Ormsby I., Boivin G.P., Darrow B.J., Saffitz J.E., Doetschman T. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. U. S. A. 92:1995;12215-12219.
6. Einheber S., Hannocks M.J., Metz C.N., Rifkin D.B., Salzer J.L. Transforming growth factor-beta 1 regulates axon/Schwann cell interactions. J. Cell Biol. 129:1995;443-458.
7. Jiang Y., McLennan I.S., Koishi K., Hendry I.A. TGF-beta2 is anterogradely and retrogradely transported in motoneurons and up-regulated after nerve injury. Neuroscience. 97:2000;735-742.
8. Letterio J.J., Geiser A.G., Kulkarni A.B., Roche N.S., Sporn M.B., Roberts A.B. Maternal rescue of transforming growth factor-beta 1 null mice. Science. 264:1994;1936-1938.
9. Letterio J.J., Geiser A.G., Kulkarni A.B., Dang H., Kong L., Nakabayashi T., Mackall C.L., Gress R.E., Roberts A.B. Autoimmunity associated with TGF-beta1 deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98:1996;2109-2119.
10. McLennan I.S., Koishi K. Cellular localisation of transforming growth factor-beta 2 and-beta 3 (TGF-β2, TGF-β3) in damaged and regenerating skeletal muscles. Dev. Dyn. 208:1997;278-289.
11. McLennan I.S., Koishi K. The transforming growth factor-betas: multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and Schwann cells. Int. J. Dev. Biol. 46:2002;559-567.
12. McLennan I.S., Koishi K., Zhang M., Murakami N. The non-synaptic expression of transforming growth factor-beta 2 is neurally regulated and varies between skeletal muscle fibre types. Neuroscience. 87:1998;845-853.
13. McLennan I.S., Poussart Y., Koishi K. Development of skeletal muscles in transforming growth factor-beta 1 (TGF-β1) null-mutant mice. Dev. Dyn. 217:2000;250-256.
14. Morgan L., Jessen K.R., Mirsky R. Negative regulation of the P0 gene in Schwann cells: suppression of P0 mRNA and protein induction in cultured Schwann cells by FGF2 and TGF beta 1, TGF beta 2 and TGF beta 3. Development. 120:1994;1399-1409.
15. Parkinson D.B., Dong Z., Bunting H., Whitfield J., Meier C., Marie H., Mirsky R., Jessen K.R. Transforming growth factor beta (TGFbeta) mediates Schwann cell death in vitro and in vivo: examination of c-Jun activation, interactions with survival signals, and the relationship of TGFbeta-mediated death to Schwann cell differentiation. J. Neurosci. 21:2001;8572-8585.
16. Peles E., Salzer J.L. Molecular domains of myelinated axons. Curr. Opin. Neurobiol. 10:2000;558-565.
17. Poussart Y., Koishi K., McLennan I.S. Connective tissue formation in the skeletal muscles of transforming growth factor-beta 1 (TGF-β1) null mutant mice. Basic Appl. Myol. 8:1998;121-128.
18. Rufer M., Flanders K., Unsicker K. Presence and regulation of transforming growth factor beta mRNA and protein in the normal and lesioned rat sciatic nerve. J. Neurosci. Res. 39:1994;412-423.
19. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M.Y., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., Doetschman T. Targeted disruption of the mouse transforming growth factor-beta1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
20. Smith K.J., Hall S.M. Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding. Curr. Opin. Neurol. 14:2001;289-298.
21. Spencer P.S., Thomas P.K. Ultrastructural studies of the dying-back process. II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseases axons. J. Neurocytol. 3:1974;763-783.
22. Stewart H.J., Rougon G., Dong Z., Dean C., Jessen K.R., Mirsky R. TGF-betas upregulate NCAM and L1 expression in cultured Schwann cells, suppress cyclic AMP-induced expression of O4 and galactocerebroside, are widely expressed in cells of the Schwann cell lineage in vivo. Glia. 15:1995;419-436.
23. Watabe K., Fukuda T., Tanaka J., Honda H., Toyohara K., Sakai O. Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities. J. Neurosci. Res. 41:1995;279-290.
24. Williams P.L., Hall S.M. Chronic Wallerian degeneration - an in vivo and ultrastructural study. J. Anat. 109:1971;487-503.
25. Young P., Suter U. Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease. Brain Res. Rev. 36:2001;213-221.